Profile data is unavailable for this security.
About the company
DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma with a 99% or higher negative predictive value (NPV). It offers DermTech Melanoma Test (the DMT), which is a non-invasive way to enhance evaluation of pigmented lesions suspicious for melanoma. Its genomics platform has been designed to work with its Smart Sticker, which provides an easy and non-invasive way to collect a skin sample, in contrast to the existing standard of care of using a scalpel to biopsy suspicious lesions. It also provides its research services and technology platform on a contract basis to pharmaceutical companies that use the technology to support their clinical trials.
- Revenue in USD (TTM)15.66m
- Net income in USD-89.63m
- Incorporated2019
- Employees206.00
- LocationDermTech Inc12340 EL CAMINO REALSAN DIEGO 92130United StatesUSA
- Phone+1 (858) 450-4222
- Fax+1 (858) 200-3877
- Websitehttps://dermtech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nemaura Medical Inc | 0.00 | -10.65m | 1.41m | 36.00 | -- | -- | -- | -- | -0.3787 | -0.3787 | 0.00 | -0.6169 | 0.00 | 0.00 | -- | 0.00 | -117.49 | -58.18 | -- | -131.96 | -- | -- | -- | -7,384.83 | 0.0305 | -1.47 | 10.81 | -- | -84.71 | -- | -1.85 | -- | 64.14 | -- |
| Catheter Precision Inc | 439.00k | -6.85m | 1.58m | 14.00 | -- | 0.0699 | -- | 3.61 | -10.32 | -10.32 | 0.6592 | 24.46 | 0.0115 | 0.3759 | 5.74 | 31,357.14 | -17.89 | -- | -19.64 | -- | 94.31 | -- | -1,559.68 | -- | 0.8047 | -- | 0.004 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
| Helius Medical Technologies Inc | -100.00bn | -100.00bn | 1.82m | 26.00 | -- | 0.3223 | -- | -- | -- | -- | -- | 2.24 | -- | -- | -- | -- | -- | -98.37 | -- | -143.57 | -- | 37.27 | -- | -1,580.66 | 3.26 | -- | -- | -- | -18.17 | 6.14 | 37.11 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -6.10m | 1.88m | 2.00 | -- | 0.473 | -- | -- | -23.10 | -23.10 | 0.00 | 3.62 | 0.00 | -- | -- | 0.00 | -114.93 | -98.31 | -189.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 1.95m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| NanoVibronix Inc | 2.85m | -3.20m | 2.12m | 10.00 | -- | 0.6063 | -- | 0.7454 | -1.72 | -1.72 | 1.45 | 1.26 | 0.516 | 0.3683 | 13.64 | 285,000.00 | -57.98 | -116.16 | -101.17 | -169.36 | 68.98 | 50.47 | -112.35 | -570.47 | 1.38 | -13.47 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| Avinger Inc | 7.62m | -16.13m | 2.17m | 68.00 | -- | -- | -- | 0.2853 | -18.16 | -18.16 | 7.49 | -2.56 | 0.4084 | 1.20 | 6.38 | 112,102.90 | -102.83 | -70.93 | -- | -131.57 | 22.43 | 30.87 | -251.78 | -208.91 | 0.4764 | -10.02 | 1.38 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| Tenon Medical Inc | 3.21m | -14.33m | 2.18m | 21.00 | -- | 6.64 | -- | 0.6786 | -7.24 | -7.24 | 1.43 | 0.9724 | 0.4108 | 2.78 | 7.25 | 153,047.60 | -183.10 | -- | -269.43 | -- | 54.70 | -- | -445.77 | -- | 2.35 | -- | 0.00 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
| DermTech Inc | 15.66m | -89.63m | 2.24m | 206.00 | -- | 0.056 | -- | 0.1429 | -2.69 | -2.69 | 0.4652 | 1.14 | 0.1119 | 11.92 | 5.06 | 76,038.84 | -64.00 | -- | -71.29 | -- | 8.51 | -- | -572.19 | -- | 3.46 | -- | 0.0013 | -- | 5.36 | -- | 13.54 | -- | -- | -- |
| Kelyniam Global Inc | 517.70k | -420.28k | 2.40m | 0.00 | -- | 4.47 | -- | 4.63 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| BIOLASE Inc | 48.83m | -38.26m | 2.66m | 157.00 | -- | -- | -- | 0.0546 | -20.50 | -20.50 | 8.64 | 0.0081 | 1.28 | 2.21 | 9.00 | 311,006.40 | -55.75 | -49.28 | -118.58 | -85.80 | 34.25 | 35.27 | -43.56 | -50.72 | 0.6409 | -5.98 | 0.9812 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 2.69m | 12.00 | -- | 30.28 | -- | 144.87 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
| Vycor Medical Inc | 1.44m | -425.52k | 2.87m | 8.00 | -- | -- | -- | 2.00 | -0.0133 | -0.0135 | 0.0425 | -0.1078 | 1.59 | 0.6672 | 6.81 | 179,572.50 | -11.22 | -47.86 | -- | -- | 89.48 | 89.60 | -7.04 | -35.42 | 0.0861 | -0.0247 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| Nuwellis Inc | 8.90m | -19.93m | 3.18m | 59.00 | -- | 21.83 | -- | 0.358 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
Data as of Jul 30 2024. Currency figures normalised to DermTech Inc's reporting currency: US Dollar USD
4.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Triatomic Management LPas of 31 Mar 2024 | 412.53k | 1.18% |
| Geode Capital Management LLCas of 31 May 2024 | 267.52k | 0.77% |
| Citadel Securities LLCas of 31 Mar 2024 | 207.38k | 0.59% |
| Abaris Investment Management AGas of 31 Dec 2023 | 197.00k | 0.56% |
| Virtu Americas LLCas of 31 Mar 2024 | 74.71k | 0.21% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 55.76k | 0.16% |
| XTX Markets LLCas of 31 Mar 2024 | 52.73k | 0.15% |
| Avantax Planning Partners, Inc.as of 31 Mar 2024 | 48.00k | 0.14% |
| Oracle Investment Management, Inc.as of 31 Mar 2024 | 47.69k | 0.14% |
| Bank Vontobel AGas of 31 Mar 2024 | 37.00k | 0.11% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
